Tom Valuck, MD, JD—Blog Editor; David Blaisdell; Manasi A Tirodkar, PhD, MS

Blog
Beyond Face Value: Why Indirect Benefits of Cancer Care Matter
Tom Valuck, MD, JD—Blog Editor; David Blaisdell; Manasi A Tirodkar, PhD, MS May 27, 2020
Tom Valuck, MD, JD, and colleagues shed light on the value of indirect benefits of effective cancer care and challenges of measuring such benefits, including insufficient data and…
Blog
Beyond Face Value: Why Indirect Benefits of Cancer Care Matter
Tom Valuck, MD, JD—Blog Editor; David Blaisdell; Manasi A Tirodkar, PhD, MS, May 27, 2020
Tom Valuck, MD, JD, and colleagues shed light on the value of indirect benefits of effective cancer care and challenges…
Blog
Oncology Quality Measurement: Angst and Ambition
Tom Valuck, MD, JD—Blog Editor; David Blaisdell; Manasi A Tirodkar, PhD, MS, September 18, 2019
In the first installment of the Quality Outlook commentary series, Tom Valuck, MD, JD, Discern Health, and colleagues…
Back to Top